Your browser doesn't support javascript.
loading
Racial, ethnic, and socioeconomic disparities in rates of stage IV prostate cancer after USPSTF category "D" recommendation against prostate-specific antigen screening: a retrospective cohort study.
Thakker, Parth U; Perry, Alan G; Hemal, Ashok K; Bercu, Caleb H; Petrou, Steven P; Pak, Raymond W; Broderick, Gregory A; Thiel, David D; Dora, Chandler D; Lyon, Timothy D; Igel, Todd C; Craven, Timothy E; Pathak, Ram A.
Afiliação
  • Thakker PU; Department of Urology, Atrium Wake Forest Baptist Health, Winston-Salem, NC, USA.
  • Perry AG; Department of Urology, Mayo Clinic, Jacksonville, FL, USA.
  • Hemal AK; Department of Urology, Atrium Wake Forest Baptist Health, Winston-Salem, NC, USA.
  • Bercu CH; Department of Urology, Atrium Wake Forest Baptist Health, Winston-Salem, NC, USA.
  • Petrou SP; Department of Urology, Mayo Clinic, Jacksonville, FL, USA.
  • Pak RW; Department of Urology, Mayo Clinic, Jacksonville, FL, USA.
  • Broderick GA; Department of Urology, Mayo Clinic, Jacksonville, FL, USA.
  • Thiel DD; Department of Urology, Mayo Clinic, Jacksonville, FL, USA.
  • Dora CD; Department of Urology, Mayo Clinic, Jacksonville, FL, USA.
  • Lyon TD; Department of Urology, Mayo Clinic, Jacksonville, FL, USA.
  • Igel TC; Department of Urology, Mayo Clinic, Jacksonville, FL, USA.
  • Craven TE; Department of Urology, Atrium Wake Forest Baptist Health, Winston-Salem, NC, USA.
  • Pathak RA; Department of Urology, Mayo Clinic, Jacksonville, FL, USA.
Transl Androl Urol ; 13(7): 1093-1103, 2024 Jul 31.
Article em En | MEDLINE | ID: mdl-39100847
ABSTRACT

Background:

In 2012 the United States Preventative Services Task Force (USPSTF) changed its prostate-specific antigen (PSA) screening recommendation to a category "D". The purpose of this study is to examine racial, ethnic, and socioeconomic differences in risk of presentation with metastatic prostate cancer (mPCa) at time of diagnosis before and after the 2012 USPSTF category "D" recommendation.

Methods:

This is a population-based cohort study. We identified patients with mPCa at diagnosis within the National Cancer Database from 2004-2017. Logistic regression models were used to examine associations of mPCa with age, race, ethnicity, geographic location, education level, income, and insurance status. Linear regression models assuming underlying binomial distribution were fitted to annual percentage of mPCa at diagnosis for years 2012-2017 to evaluate the post category "D" recommendation era.

Results:

From 2004 to 2017, 88,987 patients presented with mPCa. A higher percentage of mPCa was noted post-USPSTF category "D" recommendation, with a disproportionately greater increase observed among Hispanics and non-Hispanic Blacks [Δslope/year Hispanics (0.0092), non-Hispanic Blacks (0.0073) and non-Hispanic Whites (0.0070)]. Insurance status impacts race/ethnicity differently uninsured Hispanics were 3.66 times more likely to present with mPCa than insured Hispanics, while uninsured non-Hispanic Blacks were 2.62 times more likely to present with mPCa than insured non-Hispanic Blacks. Household income appears to be associated with differences in mPCa, particularly among non-Hispanic Blacks. Those earning <$30,000 were more likely to present with mPCa compared to higher income brackets.

Conclusions:

Since the USPSTF grade "D" recommendation against PSA screening, the percentage of mPCa at diagnosis has increased, with a higher rate of increase among Hispanic and non-Hispanic Blacks compared to non-Hispanic Whites.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article